Vik Chopra

Stock Analyst at Wells Fargo

(3.25)
# 1,081
Out of 5,120 analysts
60
Total ratings
48.15%
Success rate
5.24%
Average return

Stocks Rated by Vik Chopra

CONMED
Jan 29, 2026
Maintains: Equal-Weight
Price Target: $41$42
Current: $39.21
Upside: +7.12%
Globus Medical
Nov 7, 2025
Maintains: Overweight
Price Target: $66$79
Current: $89.70
Upside: -11.93%
Enovis
Nov 7, 2025
Maintains: Overweight
Price Target: $41$42
Current: $22.17
Upside: +89.45%
DENTSPLY SIRONA
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $15$12
Current: $12.21
Upside: -1.72%
NeuroPace
Nov 5, 2025
Maintains: Overweight
Price Target: $15$16
Current: $15.91
Upside: +0.57%
Masimo
Nov 5, 2025
Maintains: Overweight
Price Target: $190$187
Current: $138.37
Upside: +35.14%
Henry Schein
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $70$76
Current: $75.31
Upside: +0.92%
Align Technology
Oct 30, 2025
Maintains: Overweight
Price Target: $199$181
Current: $163.63
Upside: +10.62%
Alphatec Holdings
Oct 16, 2025
Maintains: Overweight
Price Target: $14$16
Current: $14.49
Upside: +10.42%
Solventum
Sep 15, 2025
Maintains: Equal-Weight
Price Target: $79$82
Current: $76.91
Upside: +6.62%
Maintains: Equal-Weight
Price Target: $17$19
Current: $23.26
Upside: -18.31%
Maintains: Equal-Weight
Price Target: $25$13
Current: $11.16
Upside: +16.49%